Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.80 SEK | +1.84% |
|
+0.87% | -7.98% |
| 06-26 | RaySearch to buy back shares for up to SEK 158m | FW |
| 06-26 | RaySearch launches share buyback of up to just over 158 million kronor | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 7,193 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -7.98% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 7,103 | 6,928 | 6,695 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -8.99% | -2.46% | -3.36% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 25.2x | 20.2x | 16.9x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 6.34x | 5.32x | 4.49x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1x | 0.8x | 0.8x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 5.1x | 4.49x | 4.01x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 5.04x | 4.32x | 3.73x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 10.8x | 9.09x | 7.73x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 19.2x | 15.1x | 12.2x |
| EV / FCF | 234x | - | - | - | 21.7x | 37.6x | 23.6x | 17.3x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.66% | 4.23% | 5.77% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 5.18 | 6.23 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 1.91% | 2.47% | 2.97% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 8.32 | 10.37 | 12.45 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 48.1% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,409 | 1,603 | 1,795 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 655 | 762 | 866 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 370 | 459 | 549 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 285 | 355 | 426 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | -90 | -265 | -498 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 209.80 | 209.80 | 209.80 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 23/02/22 | 28/02/23 | 23/02/24 | 21/02/25 | 12/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.22x | 5.04x | 10.84x | 1.91% | 740M | |
| 26.79x | 5.66x | 12.53x | -.--% | 27.84B | |
| 82.02x | 74.67x | 87.44x | 0.44% | 13.62B | |
| 93.23x | 14.71x | 63.26x | 0.69% | 5.43B | |
| -47.53x | 12.8x | -68.62x | - | 3.07B | |
| -7.2x | 73x | -7.39x | - | 2.11B | |
| 51.45x | - | - | -.--% | 1.83B | |
| -130.53x | - | - | - | 1.22B | |
| -88.48x | 971.49x | -110.91x | -.--% | 726M | |
| -104.67x | - | - | 1.27% | 715M | |
| Average | -9.97x | 165.34x | -1.84x | 0.62% | 5.73B | |
| Weighted average by Cap. | 35.30x | 40.28x | 29.59x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
